EUVIMEDEUVIMED entdecken
Crossref

Alzheimer's disease‐related brain insulin resistance and the prospective therapeutic impact of metformin

Hamed A Abosharaf iD, Yasmin Elsonbaty, Ehab Tousson, Tarek M Mohamed

Journal of Neuroendocrinology · 2024-01 · 36 (1)

DOI: 10.1111/jne.13356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 20.11.2023. Verfasst von Hamed A Abosharaf und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt. Hauptthemen laut MEDLINE: Alzheimer Disease, Insulin Resistance, Diabetes Mellitus, Type 2, Metformin. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Besides COVID‐19, two of the most critical outbreaks of our day are insulin resistance, type 2 diabetes mellitus (T2DM), and Alzheimer's disease (AD). Each disease's pathophysiology is well established. Furthermore, a substantial overlap between them has coexisted. Uncertainty remains on whether T2DM and AD are parallel illnesses with the same origin or separate illnesses linked through violent pathways. The current study was aimed at testing whether the insulin resistance in the brain results in AD symptoms or not. Insulin resistance was induced in the brains of rats using a single intracerebroventricular streptozotocin (STZ) dose. We then measured glucose, insulin receptor substrate 2 (IRS‐2), amyloid β (Aβ) deposition, and tau phosphorylation in the brain to look for signs of insulin resistance and AD. The results of this study indicated that a single dose of STZ was able to induce insulin resistance in the brain and significantly decline IRS‐2. This resistance was accompanied by obvious memory loss, Aβ deposition, and tau phosphorylation, further visible diminishing in neurotransmitters such as dopamine and acetylcholine. Furthermore, oxidative stress was increased due to the antioxidant system being compromised. Interestingly, the pancreas injury and peripheral insulin resistance coexisted with brain insulin resistance. Indeed, the antidiabetic metformin was able to enhance all these drastic effects. In conclusion, brain insulin resistance could lead to AD and vice versa. These are highly linked syndromes that could influence peripheral organs. Further studies are required to stabilize this putative pathobiology relationship between them.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseInsulin ResistanceDiabetes Mellitus, Type 2MetforminRatsAnimalsAmyloid beta-PeptidesInsulinBrainDisease Models, Animal

Stichwörter der Autor:innen

Alzheimer diseaseamyloid βbrain insulin resistanceinsulin receptor substrate 2metformin

Substanzen

Amyloid beta-PeptidesMetforminInsulin

Autor:innen und Institutionen

  • Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt.
  • Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt.

ORCID-Profile: Hamed A Abosharaf

Zitieren

APA

Abosharaf, H. A., Elsonbaty, Y., Tousson, E., & M Mohamed, T. (2024). Alzheimer's disease‐related brain insulin resistance and the prospective therapeutic impact of metformin. Journal of Neuroendocrinology, 36(1). https://doi.org/10.1111/jne.13356

Vancouver

Abosharaf HA, Elsonbaty Y, Tousson E, M Mohamed T. Alzheimer's disease‐related brain insulin resistance and the prospective therapeutic impact of metformin. Journal of Neuroendocrinology. 2024;36(1). doi:10.1111/jne.13356

BibTeX
@article{Abosharaf2024,
  author = {Abosharaf, Hamed A and Elsonbaty, Yasmin and Tousson, Ehab and M Mohamed, Tarek},
  title = {Alzheimer's disease‐related brain insulin resistance and the prospective therapeutic impact of metformin},
  journal = {Journal of Neuroendocrinology},
  year = {2024},
  volume = {36},
  number = {1},
  doi = {10.1111/jne.13356}
}
Kostenlos starten →